Differential uptake of recent Papanicolaou testing by HPV vaccination status among young women in the United States, 2008-2013

Cancer Epidemiology

Volumn 39, Issue 4, 2015, Pages 650-655

  Sauer, Ann Goding ^a   Jemal, Ahmedin ^a   Simard, Edgar P ^b   Fedewa, Stacey A ^a,b  

^a AMERICAN CANCER SOCIETY   (United States)

^b EMORY UNIVERSITY   (United States)

Author keywords

Early detection of cancer; Human papillomavirus; Papanicolaou test; Papillomavirus vaccines; Uterine cervical neoplasms

Indexed keywords

WART VIRUS VACCINE;

ADULT; ARTICLE; CANCER SCREENING; ETHNIC DIFFERENCE; FEMALE; HEALTH EDUCATION; HEALTH STATUS; HEALTH SURVEY; HISPANIC; HUMAN; MAJOR CLINICAL STUDY; NONHUMAN; PAPANICOLAOU TEST; PAPILLOMAVIRUS INFECTION; PREVALENCE; PRIORITY JOURNAL; SCREENING TEST; UNITED STATES; UTERINE CERVIX CANCER; VACCINATION; EARLY CANCER DIAGNOSIS; IMMUNOLOGY; TIME FACTOR; UTERINE CERVICAL NEOPLASMS; VIROLOGY; YOUNG ADULT;

ADULT; EARLY DETECTION OF CANCER; FEMALE; HUMANS; PAPANICOLAOU TEST; PAPILLOMAVIRUS VACCINES; TIME FACTORS; UNITED STATES; UTERINE CERVICAL NEOPLASMS; VACCINATION; YOUNG ADULT;

EID: 84938741634     PISSN: 18777821     EISSN: 1877783X     Source Type: Journal    
DOI: 10.1016/j.canep.2015.05.002     Document Type: Article

References (45)

1. Epidemiology and prevention of vaccine-preventable diseases 2012, Centers for Disease Control and Prevention, Public Health Foundation, Washington, DC.
2. Munoz N., Bosch F.X., de Sanjose S., Herrero R., Castellsagué X., Shah K.V., et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 2003, 348:518-527.
3. U.S.Food and Drug Administration FDA approves Gardasil 9 for prevention of certain cancers caused by five additional types of HPV 2014.
4. Moyer V.A. Screening for cervical cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 2012, 156:880-891. W312.
5. Saslow D., Solomon D., Lawson H.W., Killackey M., Kulasingam S.L., Cain J., et al. American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer. Am J Clin Pathol 2012, 137:516-542.
6. Williams W.W., Lu P.J., Saraiya M., Yankey D., Dorell C., Rodriguez J.L., et al. Factors associated with human papillomavirus vaccination among young adult women in the United States. Vaccine 2013, 31:2937-2946.
7. Hariri S., Unger E.R., Powell S.E., Bauer H.M., Bennett N.M., Bloch K.C., et al. Human papillomavirus genotypes in high-grade cervical lesions in the United States. J Infect Dis 2012, 206:1878-1886.
8. Niccolai L.M., Russ C., Julian P.J., Hariri S., Sinard J., Meek J.I., et al. Individual and geographic disparities in human papillomavirus types 16/18 in high-grade cervical lesions: associations with race, ethnicity, and poverty. Cancer 2013, 119:3052-3058.
9. Vidal A.C., Smith J.S., Valea F., Bentley R., Gradison M., Yarnall K.S., et al. HPV genotypes and cervical intraepithelial neoplasia in a multiethnic cohort in the southeastern USA. Cancer Causes Control 2014, 25:1055-1062.
10. Wheeler C.M., Hunt W.C., Joste N.E., Key C.R., Quint W.G., Castle P.E. Human papillomavirus genotype distributions: implications for vaccination and cancer screening in the United States. J Natl Cancer Inst 2009, 101:475-487.
11. Hopenhayn C., Christian A., Christian W.J., Watson M., Unger E.R., Lynch C.F., et al. Prevalence of human papillomavirus types in invasive cervical cancers from 7 US cancer registries before vaccine introduction. J Low Genit Tract Dis 2014, 18:182-189.
12. National Center for Health Statistic National Health Interview Surveys, 2008, 2010, 2013. Public-use data files and documentation 2014, http://www.cdc.gov/nchs/nhis/quest_data_related_1997_forward.htm.
13. Markowitz L.E., Dunne E.F., Saraiya M., Chesson H.W., Curtis C.R., Gee J., et al. Human papillomavirus vaccination. MMWR 2014, 63(RR-05):1-30.
14. Byrd T.L., Peterson S.K., Chavez R., Heckert A. Cervical cancer screening beliefs among young Hispanic women. Prev Med 2004, 38:192-197.
15. Coronado G.D., Thompson B., Koepsell T.D., Schwartz S.M., McLerran D. Use of Pap test among Hispanics and non-Hispanic Whites in a rural setting. Prev Med 2004, 38:713-722.
16. Byrne M.M., Davila E.P., Zhao W., Parker S., Hooper M.W., Caban-Martinez A., et al. Cancer screening behaviors among smokers and non-smokers. Cancer Epidemiol 2010, 34:611-617.
17. Wei F., Moore P.C., Green A.L. Geographic variability in human papillomavirus vaccination among U.S. young women. Am J Prev Med 2013, 44:154-157.
18. Bieler G.S., Brown G.G., Williams R.L., Brogan D.J. Estimating model-adjusted risks, risk differences, and risk ratios from complex survey data. Am J Epidemiol 2010, 171:618-623.
19. de Vries H., van't Riet J., Spigt M., Metsemakers J., van den Akker M., Vermunt J.K., et al. Clusters of lifestyle behaviors: results from the Dutch SMILE study. Prev Med 2008, 46:203-208.
20. Larkin F.A., Basiotis P.P., Sykes H.A., Riddick K.E., Pao E.M. Dietary patterns of women smokers and non-smokers. J Am Diet Assoc 1990, 90:230-237.
21. Documet P., Bear T.M., Flatt J.D., Macia L., Trauth J., Ricci E.M. The association of social support and education with breast and cervical cancer screening. Health Educ Behav 2015, 42:55-64.
22. National Cancer Institute HINTS brief: women's awareness of HPV and knowledge of the HPV-cervical cancer link in 2005, before the introduction of the HPV vaccine 2007, U.S. Department of Health and Human Services, National Institutes of Health, National Cancer Institute.
23. Anhang Price R., Tiro J.A., Saraiya M., Meissner H., Breen N. Use of human papillomavirus vaccines among young adult women in the United States: an analysis of the 2008 National Health Interview Survey. Cancer 2011, 117:5560-5568.
24. Cancer screening-United States, 2010. MMWR 2012, 61(3):41-45. Centers for Disease Control and Prevention.
25. Caskey R., Tessler Lindau S., Alexander G.C. Knowledge and early adoption of the HPV vaccine among girls and young women: results of a national survey. J Adolesc Health 2009, 45:453-462.
26. Beer H., Hibbitts S., Brophy S., Rahman M.A., Waller J., Paranjothy S. Does the HPV vaccination programme have implications for cervical screening programmes in the UK?. Vaccine 2014, 32:1828-1833.
27. Budd A.C., Brotherton J.M., Gertig D.M., Chau T., Drennan K.T., Saville M. Cervical screening rates for women vaccinated against human papillomavirus. Med J Aust 2014, 201:279-282.
28. Vanslyke J.G., Baum J., Plaza V., Otero M., Wheeler C., Helitzer D.L. HPV and cervical cancer testing and prevention: knowledge, beliefs, and attitudes among Hispanic women. Qual Health Res 2008, 18:584-596.
29. Kutner M., Greenberg E., Jin Y., Paulsen C. The health literacy of America's adults: results from the 2003 national assessment of adult literacy (NCES 2006-483) 2006, US Department of Education, Washington, DC.
30. Johnson C.E., Mues K.E., Mayne S.L., Kiblawi A.N. Cervical cancer screening among immigrants and ethnic minorities: a systematic review using the Health Belief Model. J Low Genit Tract Dis 2008, 12:232-241.
31. National Center for Chronic Disease Prevention and Health Promotion, Division of Cancer Prevention and Control. National Breast and Cervical Cancer Early Detection Program (NBCCEDP) 2014.
32. Simard E.P., Fedewa S., Ma J., Siegel R., Jemal A. Widening socioeconomic disparities in cervical cancer mortality among women in 26 states, 1993-2007. Cancer 2012, 118:5110-5116.
33. Rauscher G.H., Johnson T.P., Cho Y.I., Walk J.A. Accuracy of self-reported cancer-screening histories: a meta-analysis. Cancer Epidemiol Biomark Prev 2008, 17:748-757.
34. Gelman A., Nikolajski C., Schwarz E.B., Borrero S. Racial disparities in awareness of the human papillomavirus. J Women's Health 2011, 20:1165-1173.
35. Allen J.D., Mohllajee A.P., Shelton R.C., Othus M.K., Fontenot H.B., Hanna R. Stage of adoption of the human papillomavirus vaccine among college women. Prev Med 2009, 48:420-425.
36. Patient Protection and Affordable Care Act of 2010. Pub. L. No. 114-48 2010.
37. National Center for Immunization and Respiratory Diseases. Vaccines for Children Program (VFC) 2012.
38. Rosenthal S.L., Weiss T.W., Zimet G.D., Ma L., Good M.B., Vichnin M.D. Predictors of HPV vaccine uptake among women aged 19-26: importance of a physician's recommendation. Vaccine 2011, 29:890-895.
39. Jacobson Vann J.C., Szilagyi P. Patient reminder and patient recall systems to improve immunization rates. Cochrane Database Syst Rev 2005, CD003941.
40. Szilagyi P.G., Bordley C., Vann J.C., Chelminski A., Kraus R.M., Margolis P.A., et al. Effect of patient reminder/recall interventions on immunization rates: a review. J Am Med Assoc 2000, 284:1820-1827.
41. Insinga R.P., Glass A.G., Rush B.B. Pap screening in a U.S. health plan. Cancer Epidemiol Biomark Prev 2004, 13:355-360.
42. Mangtani P., Shah A., Roberts J.A. Validation of influenza and pneumococcal vaccine status in adults based on self-report. Epidemiol Infect 2007, 135:139-143.
43. Shenson D., Dimartino D., Bolen J., Campbell M., Lu P.J., Singleton J.A. Validation of self-reported pneumococcal vaccination in behavioral risk factor surveillance surveys: experience from the sickness prevention achieved through regional collaboration (SPARC) program. Vaccine 2005, 23:1015-1020.
44. Pflieger J.C., Cook E.C., Niccolai L.M., Connell C.M. Racial/ethnic differences in patterns of sexual risk behavior and rates of sexually transmitted infections among female young adults. Am J Public Health 2013, 103:903-909.
45. Drolet M., Boily M.C., Greenaway C., Deeks S.L., Blanchette C., Laprise J.F., et al. Sociodemographic inequalities in sexual activity and cervical cancer screening: implications for the success of human papillomavirus vaccination. Cancer Epidemiol Biomark Prev 2013, 22:641-652.